Get started
Author

Jaren Lerner

Observed names: J.L. Lerner, Jaren L. Lerner, Jaren Lobato Lerner
ORCID: 0000-0002-0822-9737
Observed ORCID: 0000-0002-0822-9737
OpenAlex ID: A5036497526
Advanced papillary thyroid carcinoma responding to nivolumab
2020 · Miguel Michel Ocampo, Jaren Lerner, et al. · Journal of Oncology Pharmacy Practice · 9
Bluish-gray fingernail discoloration due to the use of nivolumab
2020 · Miguel Michel Ocampo, Jaren Lerner, et al. · Journal of Oncology Pharmacy Practice · 6
Evolving therapeutic strategies for advanced hepatocellular carcinoma
2021 · Ammar Qureshi, Miguel Michel, et al. · Expert Opinion on Pharmacotherapy · 5
Management and clinical outcomes in uterine malignant mixed Müllerian tumor: Lessons from a single-institution series
2019 · Constantin A Dasanu, Andrew S Iskandar, et al. · Journal of Oncology Pharmacy Practice · 3
The Role of Intensive Chemotherapy and Radiotherapy in Plasmablastic Lymphoma: Optimizing Survival Outcomes
2024 · Philip A Haddad, Jaren Lerner, et al. · Blood · 1
PDF
Age-related clinicopathologic features and survival in papillary serous uterine cancer patients older and younger than 70: An exploratory analysis of a series of consecutive patients.
2020 · Jaren Lerner, Miguel Michel, et al. · Journal of Clinical Oncology · 1
The Role of Intensive Chemotherapy and Stem Cell Transplant in Plasmablastic Lymphoma: Optimizing Survival Outcomes
2025 · Philip A Haddad, Jaren L. Lerner, et al. · Transplantation and Cellular Therapy
The Impact of Radiotherapy on Survival Outcomes in Plasmablastic Lymphoma
2024 · P.A. Haddad, J.L. Lerner, et al. · International Journal of Radiation Oncology*Biology*Physics
Abstract 3834: Plasmablastic lymphoma provisional prognostic score
2024 · Philip A. Haddad, Jaren Lerner · Cancer Research
Plasmablastic Lymphoma Descriptors and Clinicopathologic Determinants of Survival: Analysis of a Pooled Database
2023 · Philip A Haddad, Jaren Lerner, et al. · Blood
PDF
Provisional Prognostic Score for Plasmablastic Lymphoma
2023 · Philip A Haddad, Jaren Lerner · Blood
PDF
CAR-T therapy access with Louisiana Medicaid: A single institution retrospective analysis.
2023 · Suma Sri Chennapragada, Millicent Amankwah, et al. · Journal of Clinical Oncology
PDF
Advanced uterine papillary serous cancer: Could there be a role for newer targeted therapeutic approaches or immune checkpoint inhibitors?
2021 · Constantin A Dasanu, Jaren Lerner, et al. · Journal of Oncology Pharmacy Practice
5-azacitidine reversing “spent” phase polycythemia vera back to proliferative phase and need for phlebotomy
2020 · Jaren Lerner, Miguel Michel, et al. · Journal of Oncology Pharmacy Practice
Relapsed refractory metastatic squamous cell cancer of anal canal in a patient with retroviral infection responding to cetuximab
2019 · Jaren Lerner, Miguel Michel, et al. · Journal of Oncology Pharmacy Practice
Works count: 15
Citation count: 25
H-index: 3
I10-index:
Year
Topic
Type